Skyhook accelerates the discovery and development of transformative therapies by enabling access to previously uncharted biological design spaces.
 
Our revolutionary platform integrates efficient computational (AI/ML) design, synthesis, and functional screening of diverse programmable biomolecule libraries at unprecedented speed and scale.
Skyhook is an RA Ventures* company. 
 
*RA Ventures is the venture focused division of RA Capital Management.

Biotechnology

Life Sciences

Therapeutics

Venture Capital

Skyhook

The Cambridge office focuses on advancing scientific research and corporate strategies in biopharmaceutical development.

People (9)

Jobs (0)

Other offices